Hint mode is switched on Switch off
For swift navigation between sections

Biocon Biologics
LEI 33580052P2WSQ4T37P78

PDF download

Choose all Reset all
Download Cancel
Organization name
Biocon Biologics India Limited
Country name
India
Country of registration
India
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
  • M/S&P/F
    *** / *** / ***
Public debt
800 mln USD

Upgrade to Premium features

Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market

Get access
Welcome to Cbonds

  • Full access to the largest bond database

    Bond parameters,
    prospectuses

  • Seamless
    Data export

    Analyze the data in the most efficient way

  • Bond pricing

    Current & historical quotes from 400+ stock exchanges & OTC market

  • Smart risk assessment

    Credit ratings, financial reports

Get access

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Biocon Biologics is engaged in developing high quality, affordable biosimilars that can expand access to a cutting-edge class of therapies to patients globally. It is is a subsidiary of Biocon Limited. Biocon Biologics was incorporated on 8 June, 20176 and is located in Bangalore, India.

Awards

News

12/05/2025 Biocon Biologics Achieves Major U.S. Market Access for Yesintek™, Strengthening India’s Global Biopharma Footprint
03/10/2024 New issue: Biocon Biologics issued international bonds (USG11185AA61) with the coupon rate of 6.67% in the amount of USD 800 mln maturing in 2029
24/09/2024 Upcoming Issue: Biocon Biologics
All organization news

Documentation

Stocks

Latest issues

Show all

Bond classification

  • Organization does not disclose IFRS/US GAAP financial statements

Public debt by currencies

Show more Hide

Codes

  • LEI
    33580052P2WSQ4T37P78
Registration is required to get access.